Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

INMB FY 2015 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena

INMBINmune Bio, Inc.

$38M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$48,868

Net Income

-$48,868

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

-$18,118

Free Cash Flow

-$18,118

Stock-Based Comp.

$120,000

Balance Sheet

Total Assets

$11,882

Total Liabilities

$30,750

Stockholders' Equity

-$18,868

Cash & Equivalents

$11,882

← Q3 2016 All Quarters